Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1150.0%
Neutral1045.5%
Bearish14.5%
FN2 Earnings Intelligence
Ameriprise Financial, Inc. (AMP) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 13, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 10, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 24, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 2, 2026 |
| Argus Research | Buy | Buy | Maintain | Nov 13, 2025 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 25, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 25, 2025 |
| UBS | Neutral | Buy | Downgrade | Jan 6, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 27, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 1, 2023 |
| B of A Securities | Buy | Buy | Maintain | Sep 7, 2022 |
| Citigroup | Buy | Buy | Maintain | Jun 21, 2021 |
| Barclays | Overweight | Overweight | Maintain | Apr 12, 2021 |
| CFRA | Buy | Buy | Maintain | May 13, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 26, 2017 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 14, 2016 |
| Wells Fargo | Market Perform | Outperform | Downgrade | Jan 13, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2015 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 13, 2014 |
Upside is calculated against the persisted current price $540.29. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $518 | $506.76 | -4.1% | Jul 13, 2026 |
| Morgan Stanley | Michael Cyprys | $489 | $506.62 | -9.5% | Jul 10, 2026 |
| Jefferies | Suneet Kamath | $645 | $500.16 | +19.4% | Jul 10, 2026 |
| Piper Sandler | Crispin Love | $471 | $467.19 | -12.8% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $467 | $479.63 | -13.6% | Apr 30, 2026 |
| BMO Capital | Brennan Hawken | $490 | $455.71 | -9.3% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $560 | $456.59 | +3.6% | Apr 21, 2026 |
| Morgan Stanley | Analyst unavailable | $452 | $441.86 | -16.3% | Apr 10, 2026 |
| Raymond James | Wilma Burdis | $582 | $488.19 | +7.7% | Feb 11, 2026 |
| RBC Capital | Kenneth Lee | $605 | $529.47 | +12.0% | Feb 2, 2026 |
| Piper Sandler | John Barnidge | $530 | $521.36 | -1.9% | Jan 29, 2026 |
| Morgan Stanley | Analyst unavailable | $485 | $489.17 | -10.2% | Dec 22, 2025 |
| Evercore ISI | Analyst unavailable | $570 | $490.17 | +5.5% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $484 | $486.62 | -10.4% | Oct 1, 2025 |
| Morgan Stanley | Michael Cyprys | $462 | $519.55 | -14.5% | May 15, 2025 |
| Morgan Stanley | Michael Cyprys | $509 | $514.04 | -5.8% | Oct 30, 2024 |
| Goldman Sachs | Alexander Blostein | $476 | $463.09 | -11.9% | Sep 25, 2024 |
| RBC Capital | Kenneth Lee | $500 | $432.05 | -7.5% | Jul 30, 2024 |
| UBS | Brennan Hawken | $495 | $429.25 | -8.4% | Jul 9, 2024 |
| Argus Research | Kevin Heal | $460 | $418.95 | -14.9% | May 6, 2024 |
| Morgan Stanley | Michael Cyprys | $445 | $412.86 | -17.6% | Apr 24, 2024 |
| Morgan Stanley | Michael Cyprys | $437 | $435.77 | -19.1% | Apr 9, 2024 |
| Piper Sandler | John Barnidge | $392 | $428.89 | -27.4% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $345 | $320.45 | -36.1% | Jan 10, 2023 |
| UBS | Analyst unavailable | $370 | $324.71 | -31.5% | Jan 9, 2023 |
| Goldman Sachs | Analyst unavailable | $330 | $332.97 | -38.9% | Nov 23, 2022 |
| Morgan Stanley | Analyst unavailable | $340 | $316.94 | -37.1% | Nov 17, 2022 |
| Piper Sandler | Analyst unavailable | $220 | $223.12 | -59.3% | Jul 15, 2022 |
| Piper Sandler | Analyst unavailable | $231 | $238.27 | -57.2% | Jul 8, 2022 |
| Piper Sandler | John Barnidge | $253 | $235.1 | -53.2% | Jun 21, 2022 |
| Piper Sandler | Analyst unavailable | $275 | $274.33 | -49.1% | May 27, 2022 |
| UBS | Analyst unavailable | $350 | $267.4 | -35.2% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $330 | $280.96 | -38.9% | Apr 26, 2022 |
| Jefferies | Suneet Kamath | $350 | $293.04 | -35.2% | Apr 9, 2022 |
| Piper Sandler | John Barnidge | $310 | $292.26 | -42.6% | Apr 6, 2022 |
Track every rating change on AMP the moment it posts. Free to start.
Start free